Odonate Therapeutics, Inc.
DOSING SCHEDULE FOR TESETAXEL AND CAPECITABINE
Last updated:
Abstract:
The present disclosure provides methods for treating a patient with cancer, such as metastatic breast cancer, comprising administering tesetaxel and capecitabine to the patient.
Status:
Application
Type:
Utility
Filling date:
1 Jun 2018
Issue date:
11 Jun 2020